Hiroyuki Kishimoto

  • 1343 Citations
  • 20 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hiroyuki Kishimoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 49 Similar Profiles
Neoplasms Medicine & Life Sciences
Adenoviridae Medicine & Life Sciences
Telomerase Medicine & Life Sciences
Fluorescence Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Green Fluorescent Proteins Medicine & Life Sciences
Nude Mice Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 1343 Citations
  • 20 h-Index
  • 72 Article
  • 2 Letter
  • 1 Conference contribution
2 Citations (Scopus)

Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer

Takeda, S., Shigeyasu, K., Okugawa, Y., Yoshida, K., Mori, Y., Yano, S., Noma, K., Umeda, Y., Kondo, Y., Kishimoto, H., Teranishi, F., Nagasaka, T., Tazawa, H., Kagawa, S., Fujiwara, T. & Goel, A., Mar 1 2019, In : Cancer Letters. 444, p. 127-135 9 p.

Research output: Contribution to journalArticle

RNA Editing
Colorectal Neoplasms
Fibroblasts
Tumor Microenvironment
Neoplasms
2 Citations (Scopus)

BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer

Morikawa, T., Inada, R., Nagasaka, T., Mori, Y., Kishimoto, H., Kawai, T., Umeda, Y., Mishima, H., Goel, A. & Fujiwara, T., Feb 1 2018, In : Oncology Letters. 15, 2, p. 2195-2201 7 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Drug Therapy
Mutation
Exons
Neoplasms

Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles

Mori, Y., Nyuya, A., Yasui, K., Toshima, T., Kawai, T., Taniguchi, F., Kimura, K., Inada, R., Nishizaki, M., Haraga, J., Nakamura, K., Umeda, Y., Kishimoto, H., Fujiwara, T., Katata, Y., Yamaguchi, Y. & Nagasaka, T., Jan 1 2018, In : Oncotarget. 9, 23, p. 16477-16488 12 p.

Research output: Contribution to journalArticle

Ovariectomy
Colorectal Neoplasms
Neoplasm Metastasis
Mutation
Survival

Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer

Watanabe, M., Kagawa, S., Kuwada, K., Hashimoto, Y., Shigeyasu, K., Ishida, M., Sakamoto, S., Ito, A., Kikuchi, S., Kuroda, S., Kishimoto, H., Tomida, S., Yoshida, R., Tazawa, H., Urata, Y. & Fujiwara, T., Jan 1 2018, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Biological Products
Stomach Neoplasms
Cell Biology
Precision Medicine
Recurrence
3 Citations (Scopus)

A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study)

Kagawa, S., Muraoka, A., Kambara, T., Nakayama, H., Hamano, R., Tanaka, N., Noma, K., Tanakaya, K., Kishimoto, H., Shigeyasu, K., Kuroda, S., Kikuchi, S., Kuwada, K., Nishizaki, M., Shirakawa, Y. & Fujiwara, T., Dec 30 2017, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-6 6 p.

Research output: Contribution to journalArticle

docetaxel
Stomach Neoplasms
Disease-Free Survival
Febrile Neutropenia
Chemotherapy